From USFDA
Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate Topical Solution USP (Cleocin T), 1%. Clindamycin is an antibiotic which works by stopping growth of bacteria. It is used to treat acne and help to decrease the number of acne lesions. It will be manufactured at the group's Topical manufacturing facility at Ahmedabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
